BAY1213790 Uses, Dosage, Side Effects and more
BAY1213790 is under investigation in clinical trial NCT03276143 (FactOr XIa inhibiTion for the pRevention of venOus Thromboembolism in Patients Undergoing Total Knee Arthroplasty).
| Attribute | Details |
|---|---|
| Trade Name | BAY1213790 |
| Generic | Osocimab |
| Osocimab Other Names | BAY1213790, Osocimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
